PERSPECTA

News from every angle

← Back to headlines

Zimmer Biomet Raises 2026 Outlook After Strong Q2 Revenue

Zimmer Biomet reported a 4.8% year-over-year revenue increase in Q2 and subsequently raised its adjusted EPS forecast for 2026 to $8.47-$8.59. The company also increased its organic revenue growth projection to 2.25%-3.25%.

5 Aug, 18:41 — 5 Aug, 18:41
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed1h ago

Zimmer Biomet forecasts 2026 adjusted EPS of $8.47-$8.59 as it raises organic revenue growth to 2.25%-3.25%

Read full article →

Coverage Timeline

First report: Yahoo · 5 Aug, 16:15Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
Yahoo5 Aug, 16:15First to report

Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook

2h later
seeking-alpha5 Aug, 18:41Latest update

Zimmer Biomet forecasts 2026 adjusted EPS of $8.47-$8.59 as it raises organic revenue growth to 2.25%-3.25%

Related Stories

Kymera Sets 2026 KT-621 AD Data Target, Maintains Cash Runway into 2029

23m ago

Verano Aims for 10-15% Cultivation Yield Gains, Tightens 2026 CapEx

24m ago

1stDibs Forecasts Q3 GMV and Anticipates 2026 Growth

24m ago

Phillips 66 Targets Net Debt, Awaits Western Gateway FID

24m ago